Oncolytics Biotech Inc.

NASDAQ: ONCY · Real-Time Price · USD
1.08
0.14 (14.86%)
At close: Aug 15, 2025, 3:59 PM
1.05
-2.79%
After-hours: Aug 15, 2025, 07:06 PM EDT

Oncolytics Biotech Balance Sheet Statement

Financials in CAD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
15.94M 34.91M 11.67M 41.26M
Short-Term Investments
n/a 3.38M 20.47M 1.36M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a 998K n/a
Receivables
68K 15K 521K n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
980K n/a n/a n/a
Total Current Assets
18.88M 38.17M 35.68M 44.9M
Property-Plant & Equipment
1.31M 647K 652K 976.29K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.31M 647K 1.65M 976.29K
Total Assets
20.19M 38.82M 37.33M 45.88M
Account Payables
1.09M 1.08M 2.25M 594K
Deferred Revenue
n/a n/a n/a -594K
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
1.62M 532K 79K 407.84K
Total Current Liabilities
6.69M 4.24M 3.94M 2.69M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a 6.73M n/a
Total Long-Term Liabilities
7.52M 7.02M 6.89M 7.09M
Total Liabilities
14.2M 11.26M 10.83M 9.78M
Total Debt
1.06M 423K 373K 654.75K
Common Stock
438.19M 430.91M 404.04M 391.35M
Retained Earnings
-477.71M -446M -418.25M -393.42M
Comprehensive Income
961K 544K 662K 387.74K
Shareholders Equity
5.98M 27.56M 26.5M 36.1M
Total Investments
n/a 3.38M 20.47M 1.36M